News & Perspective

Jun 28, 2019

Jun 28, 2019

ASP Scan (Weekly) for Jun 28, 2019

Dental overprescribing in Japan
Rapid tests and unneeded antibiotics
Procalcitonin meta-analysis
Overprescribing for pediatric UTIs
Fast-track for pneumonia antibiotic
Highly resistant gonorrhea in Taiwan
New pneumonia antibiotic
UK AMR funding
Core stewardship and antibiotic use
Antibiotic overuse in dengue

Feb 08, 2019

Feb 08, 2019

ASP Scan (Weekly) for Feb 08, 2019

Inadequate TB drug-susceptibility testing
New UK guidance on antibiotics for acute cough
FDA to review new Merck antibiotics
CARB-X novel antibiotic funding
Antibiotic prescribing intervention in China
Candida auris fungemia
Microbiology test use in Norway
CRP-guided therapy
Formulary restriction policy
New CARB-X funding

Sep 14, 2018

Sep 14, 2018

ASP Scan (Weekly) for Sep 14, 2018

UK-India diagnostics effort
Probiotics and antibiotic use in kids
Candida auris in New York
Resistance and rising temps
European One Health AMR plan
India bans combo drugs
MDR bacteria in farmed salmon
Resistant E coli in dogs
Essential-antibiotic price hike
Antibiotics and cough
Piperacillin-tazobactam trial results
Double antibiotic for pneumonia
C diff in food animals
Accessible antimicrobial resistance data

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»